GPCR Structure Therapeutics Inc.
Health Care, filed as STRUCTURE THERAPEUTICS INC (SPONSORED ADS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
In 2026 Q2 David Witzke added to Structure Therapeutics.
Who owns this now
Largest portfolio weights among holders, up to 0.8% (David Witzke, Avidity Partners Management). Not free-float ownership.
Who owns GPCR
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| David Witzke, Avidity Partners Management | Add +104.2% | 98,000 | $5.3M | History | |
| Nathan Fischel, Dafna Capital Management | Hold | 46,500 | $2.5M | History |
Insider trades
Open-market buys and sales by GPCR's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- None no planned (10b5-1) sales
No open-market buys or sales on file.
Also filed in the last 12 months, not counted as buying or selling: 8 stock grants, 7 share withholdings for taxes, 6 conversions, and 5 option exercises.
SEC filings
Recent issuer filings from EDGAR, 12 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| 424B5 | Filing Doc | ||
| 8-K | 1.01,2.02,8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 10-K | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Balance sheet
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.